Independent market expert Ratnesh Kumar continues to remain positive on the IT sector, but says pharma as a whole is valuation-wise expensive. He is underweight on the auto-ancillary space and believes it is perhaps done with its best phase
first published: Oct 1, 2015 10:00 am
A collection of the most-viewed Moneycontrol videos.
Sensex, Nifty resume rally after 2-day pause, financials shine bright | Closing Bell
Maran Govindasamy of Unifi Capital on Investment Insights from India’s Consumption Story
Nifty Bulls Likely To Tread With Caution With Eye On Axis Bank Q2 Earnings |Opening Bell Live
Live: Nifty slips below 25,200, LG Electronics shares down after blockbuster debut | Closing Bell
You are already a Moneycontrol Pro user.